Company
Sequana Medical NV
Headquarters: Gent, Belgium
Employees: 50
CEO: Mr. Ian Crosbie
Market Cap
€40.1 Million
EUR as of July 1, 2024
US$43.0 Million
Sequana Medical NV Categories
Belgium Healthcare Medical DevicesBelgium Healthcare Belgium Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory ascites due to liver cirrhosis and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal (DSR) to manage fluid overload in heart failure patients. It operates in Switzerland, Germany, France and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Sequana Medical NV has the following listings and related stock indices.
Stock: XSTU: 2SE wb_incandescent
Stock: FSX: 2SE wb_incandescent